Recognizing the Importance of Respiratory Syncytial Virus in Chronic Obstructive Pulmonary Disease

REFERENCES

• Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970–2002. JAMA 2005; 294: 1255–1259
   PubMed Web of Science ®Google Scholar
• Roman J, Perez R L. COPD in VA hospitals. Clinical Cornerstone 2003; 5: 37–44
   PubMedGoogle Scholar
• Donaldson G C, Wedzicha J A. COPD exacerbations: 1. Epidemiology. Thorax 2006; 61: 164–168
   PubMed Web of Science ®Google Scholar
• Sapey E, Stockley R A. COPD exacerbations: 2. Aetiology. Thorax 2006; 61: 250–258
   PubMed Web of Science ®Google Scholar
• Rohde G, Wiethege A, Borg I, Kauth M, Bauer T T, Gillissen A, Bufe A, Schultze-Werninghaus G. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 2003; 58: 37–42
   PubMed Web of Science ®Google Scholar
• Beckham J D, Cadena A, Lin J, Piedra P A, Glezen W P, Greenberg S B, Atmar R L. Respiratory viral infections in patients with chronic obstructive pulmonary disease. J Infect 2005; 50: 322–330
   PubMed Web of Science ®Google Scholar
• Falsey A R, Hennessey P A, Formica M A, Cox C, Walsh E E. Respiratory syncytial virus infection in elderly and high-risk adults. N Eng J Med 2005; 352: 1749–1759
   PubMed Web of Science ®Google Scholar
• Falsey A R, Criddle M C, Walsh E E. Detection of respiratory syncytial virus and human metapneumovirus by reverse transcription polymerase chain reaction in adults with and without respiratory illness. J Clin Virol 2006; 35: 46–50
   PubMed Web of Science ®Google Scholar
• Falsey A R, Formica M A, Hennessey P A, Criddle M M, Sullender W M, Walsh E E. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173: 639–643
   PubMed Web of Science ®Google Scholar
• Hall C B. Respiratory syncytial virus and parainfluenza virus. N Eng J Med 2001; 344: 1917–1928
   PubMed Web of Science ®Google Scholar
• Chanock R, Roizman B, Myers R. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization. Am J Hyg 1957; 66: 281–290
   PubMed Web of Science ®Google Scholar
• Louie J K, Hacker J K R. G., Mark J, Maselli J H, Yagi S, Drew W L. Characterization of viral agents causing acute respiratory infection in a San Francisco university medical center clinic during the influenza season. Clin Infect Dis 2005; 41: 822–828
   PubMed Web of Science ®Google Scholar
• Johnston S L, Pattemore P K, Sanderson G, Smith S, Lampe F, Josephs L, Symington P, O'Toole S, Myint S H, Tyrrell D AJ, Holgate S T. Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. Br Med J 1995; 310: 1225–1228
   PubMed Web of Science ®Google Scholar
• Nicholson K G, Kent J, Ireland D C. Respiratory viruses and exacerbations of asthma in adults. Br Med J 1993; 307: 982–986
   PubMed Web of Science ®Google Scholar
• Soler N, Torres A, Ewig S, Gonzalez J, Celis R, El-Ebiary M, Hernandez C, Rodriguez-Roisin R. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998; 157: 1498–1505
   PubMed Web of Science ®Google Scholar
• Ko F W, Ip M, Chan P K, Fok J P, Chan M C, Ngai J C, Chan D P, Hui D S. A 1-year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD. Chest 2007; 131: 44–52
   PubMed Web of Science ®Google Scholar
• Cameron R J, de Wit D, Welsh T N, Ferguson J, Grissell T V, Rye P J. Virus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilation. Intensive Care Med 2006; 32: 968–970
   PubMedGoogle Scholar
• Falsey A R, Formica M A, Treanor J J, Walsh E E. Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding. J Clin Microbiol 2003; 41: 4160–4165
   PubMed Web of Science ®Google Scholar
• Borg I, Rohde G, Loseke S, Bittscheidt J, Schultze-Werninghaus G, Stephan V, Bufe A. Evaluation of a quantitative real-time PCR for the detection of respiratory syncytial virus in pulmonary diseases. Eur Resp J 2003; 21: 944–951
   PubMed Web of Science ®Google Scholar
• Wilkinson T M, Donaldson G C, Johnston S L, Openshaw P J, Wedzicha J A. Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173: 871–876
   PubMed Web of Science ®Google Scholar
• Sethi S, Evans N, Grant B J, Murphy T F. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Eng J Med 2002; 347: 465–471
   PubMed Web of Science ®Google Scholar
• Burge S, Wedzicha J A. COPD exacerbations: definitions and classifications. Eur Resp J 2003; 21(Suppl 41)46s–53s
   Web of Science ®Google Scholar
• Sunyer J, Sáez M, Murillo C, Castellsague J, Martínez F, Antó J M. Air pollution and emergency room admissions for chronic obstructive pulmonary disease: a 5-year study. Am J Epidemiol 1993; 137: 701–705
   PubMed Web of Science ®Google Scholar
• Ball P. Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest 1995; 108: 43S–52S
   PubMed Web of Science ®Google Scholar
• Connors A FJ, Dawson N V, Thomas C, Harrell F EJ, Desbiens N, Fulkerson W J, Kussin P, Bellamy P, Goldman L, Knaus W A. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (study to understand prognoses and preferences for outcomes and risks of treatments). Am J Respir Crit Care Med 1996; 154: 959–967
   PubMed Web of Science ®Google Scholar
• Walsh E E, Peterson D R, Falsey A R. Risk factors for severe respiratory syncytial virus infection in elderly persons. J Infect Dis 2004; 189: 233–238
   PubMed Web of Science ®Google Scholar
• Thompson W W, Shay D K, Weintraub E, Brammer L, Cox N, Anderson L J, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289: 179–186
   PubMed Web of Science ®Google Scholar
• Lee F EH, Walsh E E, Falsey A R, Betts R F, Treanor J J. Experimental infection of humans with A2 respiratory syncytial virus. Antiviral Res 2004; 63: 191–196
   PubMed Web of Science ®Google Scholar
• Glezen P, Denny F W. Epidemiology of acute lower respiratory disease in children. N Engl J Med 1973; 288: 498–505
   PubMed Web of Science ®Google Scholar
• Upshur R EG, Moineddin R, Crighton E J, Mamdani M. Interactions of viral pathogens on hospital admissions for pneumonia, croup and chronic obstructive pulmonary diseases: Results of a multivariate time-series analysis. Epidemiol Infect 2006; 134: 1174–1178
   PubMed Web of Science ®Google Scholar
• Mullooly J P, Bridges C B, Thompson W W, Chen J, Weintraub E, Jackson L A, Black S, Shay D K, Vaccine Safety Datalink Adult Working Group. Influenza- and RSV-associated hospitalizations among adults. Vaccine 2007; 25: 846–855
   PubMed Web of Science ®Google Scholar
• Dakhama A, Vitalis T Z, Hegele R G. Persistence of respiratory syncytial virus (RSV) infection and development of RSV-specific IgG1 response in a guinea-pig model of acute bronchiolitis. Eur Respir J 1997; 10: 20–26
   PubMed Web of Science ®Google Scholar
• Bramley A M, Vitalis T Z, Wiggs B R, Hegele R G. Effects of respiratory syncytial virus persistence on airway responsiveness and inflammation in guinea-pigs. Eur Resp J 1999; 14: 1061–1067
   PubMed Web of Science ®Google Scholar
• Schwarze J, O'Donnell D R, Rohwedder A, Openshaw P J. Latency and persistence of respiratory syncytial virus despite T cell immunity. Am J Respir Crit Care Med 2004; 169: 801–805
   PubMed Web of Science ®Google Scholar
• Cubie H A, Duncan L A, Marshall L A, Smith N M. Detection of respiratory syncytial virus nucleic acid in archival postmortem tissue from infants. Pediatr Pathol Lab Med 1997; 17: 927–938
   PubMedGoogle Scholar
• Hogg J C. Role of latent viral infections in chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 2001; 164: S71–S75
   PubMed Web of Science ®Google Scholar
• Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade T W, Jeffries D J, Johnston S L, Wedzicha J A. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1618–1623
   PubMed Web of Science ®Google Scholar
• Greenberg S B, Allen M, Wilson J, Atmar R L. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162: 167–173
   PubMed Web of Science ®Google Scholar
• Croxton T L, Weinmann G G, Senior R M, Wise R A, Crapo J D, Buist A S. Clinical research in chronic obstructive pulmonary disease-needs and opportunities. Am J Respir Crit Care Med 2003; 17: 1142–1149
   Google Scholar
• Robbins C S, Dawe D E, Goncharova S I, Pouladi M A, Drannik A G, Swirski F K, Cox G, Stämpfli M R. Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness. Am J Respir Cell Mol Biol 2004; 30: 202–211
   PubMed Web of Science ®Google Scholar
• Robbins C S, Bauer C M, Vujicic N, Gaschler G J, Lichty B D, Brown E G, Stämpfli M R. Cigarette smoke impacts immune inflammatory responses to influenza in mice. Am J Respir Crit Care Med 2006; 174: 1342–1351
   PubMed Web of Science ®Google Scholar
• Huchon G J, Russell J A, Barritault L G, Lipavsky A, Murray J F. Chronic air-flow limitation does not increase respiratory epithelial permeability assessed by aerosolized solute, but smoking does. Am Rev Respir Dis 1984; 130: 457–460
   PubMed Web of Science ®Google Scholar
• Monick M M, Yarovinsky T O, Powers L S, Butler N S, Carter A B, Gudmundsson G, Hunninghake G W. Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin. J Biol Chem 2003; 278: 53035–53044
   PubMed Web of Science ®Google Scholar
• Tal G, Mandelberg A, Dalal I, Cesar K, Somekh E, Tal A, Oron A, Itskovich S, Ballin A, Houri S, Beigelman A, Lider O, Rechavi G, Amariglio N. Association between common toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J Infect Dis 2004; 189: 2057–2063
   PubMed Web of Science ®Google Scholar
• Puthothu B, Forster J, Heinzmann A, Krueger M. TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease. Dis Markers 2006; 22: 303–308
   PubMed Web of Science ®Google Scholar
• Hull J, Thomson A, Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 2000; 55: 1023–1027
   PubMed Web of Science ®Google Scholar
• Löfgren J, Rämet M, Renko M, Marttila R, Hallman M. Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants. J Infect Dis 2002; 185: 283–289
   PubMed Web of Science ®Google Scholar
• Lahti M, Lofgren J, Marttila R, Renko M, Klaavuniemi T, Haataja R, Ramet M, Hallman M. Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection. Pediatr Res 2002; 51: 696–699
   PubMed Web of Science ®Google Scholar
• Hoebee B, Rietveld E, Bont L, Oosten M, Hodemaekers H M, Nagelkerke N J, Neijens H J, Kimpen J L, Kimman T G. Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms. J Infect Dis 2003; 187: 2–11
   PubMed Web of Science ®Google Scholar
• Hull J, Rowlands K, Lockhart E, Moore C, Sharland M, Kwiatkowski D. Variants of the chemokine receptor CCR5 are associated with severe bronchiolitis caused by respiratory syncytial virus. J Infect Dis 2003; 188: 904–907
   PubMed Web of Science ®Google Scholar
• Hoebee B, Bont L, Rietveld E, van Oosten M, Hodemaekers H M, Nagelkerke N J, Neijens H J, Kimpen J L, Kimman T G. Influence of promoter variants of interleukin-10, interleukin-9, and tumor necrosis factor-alpha genes on respiratory syncytial virus bronchiolitis. J Infect Dis 2004; 189: 239–247
   PubMed Web of Science ®Google Scholar
• Puthothu B, Krueger M, Forster J, Heinzmann A. Association between severe respiratory syncytial virus infection and IL13/IL4 haplotypes. J Infect Dis 2006; 193: 438–441
   PubMed Web of Science ®Google Scholar
• Puthothu B, Krueger M, Heinze J, Forster J, Heinzmann A. Haplotypes of surfactant protein C are associated with common paediatric lung diseases. Pediatr Allergy Immunol 2006; 17: 572–577
   PubMed Web of Science ®Google Scholar
• Puthothu B, Forster J, Heinze J, Heinzmann A, Krueger M. Surfactant protein B polymorphisms are associated with severe respiratory syncytial virus infection, but not with asthma. BMC Pulm Med 2007; 7: 6
   PubMedGoogle Scholar
• Krueger M, Puthothu B, Heinze J, Forster J, Heinzmann A. Genetic polymorphisms of adhesion molecules in children with severe RSV-associated diseases. Int J Immunogenet 2006; 33: 233–235
   PubMed Web of Science ®Google Scholar
• Becker S, Soukup J, Yankaskas J R. Respiratory syncytial virus infection of human primary nasal and bronchial epithelial cell cultures and bronchoalveolar macrophages. Am J Respir Cell Mol Biol 1992; 6: 369–374
   PubMed Web of Science ®Google Scholar
• Look D C, Walter M J, Williamson M R, Pang L, You Y, Sreshta J N, Johnson J E, Zander D S, Brody S L. Effects of paramyxoviral infection on airway epithelial cell Foxj1 expression, ciliogenesis, and mucociliary function. Am J Pathol 2001; 159: 2055–2069
   PubMed Web of Science ®Google Scholar
• Johnson J E, Gonzales R A, Olson S J, Wright P F, Graham B S. The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol 2007; 20: 108–119
   PubMed Web of Science ®Google Scholar
• Levin S J. Bronchial epithelial cell-cytokine interactions in airway inflammation. J Invest Med 1995; 43: 241–249
   PubMed Web of Science ®Google Scholar
• Holtzman M J, Look D C, Sampath D, Castro M, Koga T, Walter M J. Control of epithelial immune-response genes and implications for airway immunity and inflammation. Proc Assoc Am Phys 1998; 110: 1–11
   PubMedGoogle Scholar
• Look D C, Brody S L. Engineering viral vectors to subvert the airway defense response. Am J Respir Cell Mol Biol 1999; 20: 1103–1106
   PubMed Web of Science ®Google Scholar
• Noah T L, Becker S. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am J Physiol (Lung Cell Mol Physiol) 1993; 265: L472–L478
   Google Scholar
• Elias J A, Zheng T, Einarsson O, Landry M, Trow T, Rebert N, Panuska J. Epithelial interleukin-11 -regulation by cytokines, respiratory syncytial virus, and retinoic acid. J Biol Chem 1994; 269: 22261–22268
   PubMed Web of Science ®Google Scholar
• Stark J M, Godding V, Sedgwick J B, Busse W W. Respiratory syncytial virus infection enhances neutrophil and eosinophil adhesion to cultured respiratory epithelial cells—roles of CD18 and intercellular adhesion molecule-1. J Immunol 1996; 156: 4774–4782
   PubMed Web of Science ®Google Scholar
• Garofalo R, Mei F, Espejo R, Ye G, Haeberle H, Baron S, Ogra P L, Reyes V E. Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-β and IL-1α. J Immunol 1996; 157: 2506–2513
   PubMed Web of Science ®Google Scholar
• Saito T, Deskin R W, Casola A, Haeberle H, Olszewska B, Ernst P B, Alam R, Ogra P L, Garofalo R. Respiratory syncytial virus induces selective production of the chemokine rantes by upper airway epithelial cells. J Infect Dis 1997; 175: 497–504
   PubMed Web of Science ®Google Scholar
• Becker S, Reed W, Henderson F W, Noah T L. RSV infection of human airway epithelial cells causes production of the β -chemokine RANTES. Am J Physiol (Lung Cell Mol Physiol) 1997; 272: L512–L520
   PubMed Web of Science ®Google Scholar
• Olszewska-Pazdrak B, Casola A, Saito T, Alam R, Crowe S E, Mei F, Ogra P L, Garofalo R P. Cell-specific expression of RANTES, MCP-1, and MIP-1α by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J Virol 1998; 72: 4756–4764
   PubMed Web of Science ®Google Scholar
• Koga T, Sardina E, Tidwell R M, Pelletier M, Look D C, Holtzman M J. Virus-inducible expression of a host chemokine gene relies on replication-linked mRNA stabilization. Proc Natl Acad Sci USA 1999; 9(6)5680–5685
   Google Scholar
• Garofalo R P, Haeberle H. Epithelial regulation of innate immunity to respiratory syncytial virus. Am J Respir Cell Mol Biol 2000; 23: 581–585
   PubMed Web of Science ®Google Scholar
• Kao Y J, Piedra P A, Larsen G L, Colasurdo G N. Induction and regulation of nitric oxide synthase in airway epithelial cells by respiratory syncytial virus. Am J Respir Crit Care Med 2001; 163: 532–539
   PubMed Web of Science ®Google Scholar
• Milner M E, Monte S DL, Hutchins G M. Fatal respiratory syncytial virus infection in severe combined immunodeficiency syndrome. Am J Dis Child 1985; 139: 1111–1114
   PubMedGoogle Scholar
• Cannon M J, Openshaw P JM, Askonas B A. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J Exp Med 1988; 168: 1163–1168
   PubMed Web of Science ®Google Scholar
• Tang Y W, Graham B S. T cell source of type I cytokines determines illness patterns in respiratory syncytial virus-infected mice. J Clin Invest 1997; 99: 2183–2191
   PubMed Web of Science ®Google Scholar
• Durbin J E, Johnson T R, Durbin R K, Mertz S E, Morotti R A, Peebles R S, Graham B S. The role of IFN in respiratory syncytial virus pathogenesis. J Immunol 2002; 168: 2944–2951
   PubMed Web of Science ®Google Scholar
• Stark G R, Kerr I M, Williams B R, Silverman R H, Schreiber R D. How cells respond to interferons. Annu Rev Biochem 1998; 67: 227–264
   PubMed Web of Science ®Google Scholar
• Ramaswamy M, Shi L, Monick M M, Hunninghake G W, Look D C. Specific inhibition of type I interferon signal transduction by respiratory syncytial virus. Am J Respir Cell Mol Biol 2004; 30: 893–900
   PubMed Web of Science ®Google Scholar
• Katze M G, He Y, Gale M J. Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2002; 2: 675–687
   PubMed Web of Science ®Google Scholar
• Look D C, Roswit W T, Frick A G, Gris-Alevy Y, Dickhaus D M, Walter M J, Holtzman M J. Direct suppression of Stat1 function during adenoviral infection. Immunity 1998; 9: 871–880
   PubMed Web of Science ®Google Scholar
• Taniguchi T, Takaoka A. A weak signal for strong responses: interferon-α /β revisited. Nature Rev 2001; 2: 378–386
   Web of Science ®Google Scholar
• Der S D, Zhou A, Williams B RG, Silverman R H. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays. Proc Natl Acad Sci USA 1998; 95: 15623–15628
   PubMed Web of Science ®Google Scholar
• Ramaswamy M, Shi L, Varga S M, Barik S, Behlke M A, Look D C. Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 2006; 344: 328–339
   PubMed Web of Science ®Google Scholar
• Bitko V, Shulyayeva O, Mazumder B, Musiyenko A, Ramaswamy M, Look D C, Barik S. Nonstructural proteins of respiratory syncytial virus suppress premature apoptosis by an NF-kappaB-dependent, interferon-independent mechanism and facilitate virus growth. J Virol 2007; 81: 1786–1795
   PubMed Web of Science ®Google Scholar
• Thomas K W, Monick M M, Staber J M, Yarovinsky T, Carter A B, Hunninghake G W. Respiratory syncytial virus inhibits apoptosis and induces NF-kappa B activity through a phosphatidylinositol 3-kinase-dependent pathway. J Biol Chem 2002; 277: 492–501
   PubMed Web of Science ®Google Scholar
• Monick M M, Cameron K, Staber J, Powers L S, Yarovinsky T O, Koland J G, Hunninghake G W. Activation of the epidermal growth factor receptor by respiratory syncytial virus results in increased inflammation and delayed apoptosis. J Biol Chem 2005; 280: 2147–2158
   PubMed Web of Science ®Google Scholar
• Groskreutz D J, Monick M M, Yarovinsky T O, Powers L S, Quelle D E, Varga S M, Look D C, Hunninghake G W. Respiratory syncytial virus decreases p53 protein to prolong survival of airway epithelial cells. J Immunol 2007; 179: 2741–2747
   PubMed Web of Science ®Google Scholar
• Rudd B D, Burstein E, Duckett C S, Li X, Lukacs N W. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J Virol 2005; 79: 3350–3357
   PubMed Web of Science ®Google Scholar
• Groskreutz D J, Monick M M, Powers L S, Yarovinsky T O, Look D C, Hunninghake G W. Respiratory syncytial virus induces TLR3 protein and protein kinase R, leading to increased double-stranded RNA responsiveness in airway epithelial cells. J Immunol 2006; 176: 1733–1740
   PubMed Web of Science ®Google Scholar
• Kreindler J L, Jackson A D, Kemp P A, Bridges R J, Danahay H. Inhibition of chloride secretion in human bronchial epithelial cells by cigarette smoke extract. Am J Physiol (Lung Cell Mol Physiol) 2005; 288: L894–L902
   PubMedGoogle Scholar
• Gelbman B D, Heguy A, O'Connor T P, Zabner J, Crystal R G. Upregulation of pirin expression by chronic cigarette smoking is associated with bronchial epithelial cell apoptosis. Respir Res 2007; 8: 10
   PubMed Web of Science ®Google Scholar
• Pesci A, Majori M, Cuomo A, Borciani N, Bertacco S, Cacciani G, Gabrielli M. Neutrophils infiltrating bronchial epithelium in chronic obstructive pulmonary disease. Respir Med 1998; 92: 863–870
   PubMed Web of Science ®Google Scholar
• Takizawa H TM, Takami K, Ohtoshi T, Ito K, Satoh M, Okada Y, Yamasawa F, Nakahara K, Umeda A. Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 2001; 163: 1476–1483
   PubMed Web of Science ®Google Scholar
• Puchelle E, Zahm J M, Tournier J M, Coraux C. Airway epithelial repair, regeneration, and remodeling after injury in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3: 726–733
   PubMedGoogle Scholar
• Caramori G, Ito K, Contoli M, Di Stefano A, Johnston S L, Adcock I M, Papi A. Molecular mechanisms of respiratory virus-induced asthma and COPD exacerbations and pneumonia. Curr Med Chem 2006; 13: 2267–2290
   PubMed Web of Science ®Google Scholar
• Beem M, Egerer R, Anderson J. Respiratory syncytial virus neturalizing antibodies in persons residing in Chicago, Illinois. Pediatrics 1964; 34: 761–770
   PubMed Web of Science ®Google Scholar
• Welliver R C, Kaul T N, Putnam T I, Sun M, Riddlesberger K, Ogra P L. The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses. J Pediatr 1980; 96: 808–813
   PubMed Web of Science ®Google Scholar
• Glezen W P, Paredes A, Allison J E, Taber L H, Frank A L. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr 1981; 98: 708–715
   PubMed Web of Science ®Google Scholar
• de Sierra T M, Kumar M L, Wasser T E, Murphy B R, Subbarao E K. Respiratory syncytial virus-specific immunoglobulins in preterm infants. J Pediatr 1993; 122: 787–791
   PubMed Web of Science ®Google Scholar
• The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998; 102: 531–537
   PubMed Web of Science ®Google Scholar
• Piedra P A, Jewell A M, Cron S G, Atmar R L, Glezen W P. Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies. Vaccine 2003; 21: 3479–3482
   PubMed Web of Science ®Google Scholar
• Walsh E E, Falsey A R. Age related differences in humoral immune response to respiratory syncytial virus infection in adults. J Med Virol 2004; 73: 295–299
   PubMed Web of Science ®Google Scholar
• Walsh E E, Falsey A R. Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults. J Infect Dis 2004; 190: 373–378
   PubMed Web of Science ®Google Scholar
• Falsey A R, Singh H K, Walsh E E. Serum antibody decay in adults following natural respiratory syncytial virus infection. J Med Virol 2006; 78: 1493–1497
   PubMed Web of Science ®Google Scholar
• Meyer K C. Aging. Proc Am Thorac Soc 2005; 2: 433–439
   PubMedGoogle Scholar
• Hall C B, Powell K R, MacDonald N E, Gala C L, Menegus M E, Suffin S C, Cohen H J. Respiratory syncytial viral infection in children with compromised immune function. N Eng J Med 1986; 315: 77–81
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang Y, Gilmore X, Xu K, Wyde P R, Mbawuike I N. An aged mouse model for RSV infection and diminished CD8(+) CTL responses. Exp Biol Med 2002; 227: 133–140
   PubMed Web of Science ®Google Scholar
• Liu B, Kimura Y. Local immune response to respiratory syncytial virus infection is diminished in senescence-accelerated mice. J Gen Virol 2007; 88: 2552–2558
   PubMed Web of Science ®Google Scholar
• Mbawuike I N, Wells J, Byrd R, Cron S G, Glezen W P, Piedra P A. HLA-restricted CD8+ cytotoxic T lymphocyte, interferon-gamma, and interleukin-4 responses to respiratory syncytial virus infection in infants and children. J Infect Dis 2001; 183: 687–696
   PubMed Web of Science ®Google Scholar
• de Bree G J, Heidema J, van Leeuwen E M, van Bleek G M, Jonkers R E, Jansen H M, van Lier R A, Out T A. Respiratory syncytial virus-specific CD8+ memory T cell responses in elderly persons. J Infect Dis 2005; 191: 1710–1718
   PubMed Web of Science ®Google Scholar
• Looney R J, Falsey A R, Walsh E, Campbell D. Effect of aging on cytokine production in response to respiratory syncytial virus infection. J Infect Dis 2002; 185: 682–685
   PubMed Web of Science ®Google Scholar
• Lee F E, Walsh E E, Falsey A R, Liu N, Liu D, Divekar A, Snyder-Cappione J E, Mosmann T R. The balance between influenza- and RSV-specific CD4 t cells secreting IL-10 or IFNgamma in young and healthy-elderly subjects. Mech Ageing Dev 2005; 126: 1223–1229
   PubMed Web of Science ®Google Scholar
• Linton P J, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol 2004; 5: 133–139
   PubMed Web of Science ®Google Scholar
• de Bree G J, Daniels H, Schilfgaarde M, Jansen H M, Out T A, van Lier R A, Jonkers R E. Characterization of CD4+ memory T cell responses directed against common respiratory pathogens in peripheral blood and lung. J Infect Dis 2007; 195: 1718–1725
   PubMed Web of Science ®Google Scholar
• Hancock A, Armstrong L, Gama R, Millar A. Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. Am J Respir Cell Mol Biol 1998; 18: 60–65
   PubMed Web of Science ®Google Scholar
• Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol Rev 2004; 202: 175–190
   PubMed Web of Science ®Google Scholar
• Lee C G, Homer R J, Zhu Z, Lanone S, Wang X, Koteliansky V, Shipley J M, Gotwals P, Noble P, Chen Q, Senior R M, Elias J A. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta (1). J Exp Med 2001; 194: 809–821
   PubMed Web of Science ®Google Scholar
• Ke B, Shen X D, Zhai Y, Gao F, Busuttil R W, Volk H D, Kupiec-Weglinski J W. Heme oxygenase 1 mediates the immunomodulatory and antiapoptotic effects of interleukin 13 gene therapy in vivo and in vitro. Hum Gene Ther 2002; 13: 1845–1857
   PubMed Web of Science ®Google Scholar
• Wynn T A. IL-13 effector functions. Annu Rev Immunol 2003; 21: 425–456
   PubMed Web of Science ®Google Scholar
• Zhou W, Hashimoto K, Moore M L, Elias J A, Zhu Z, Durbin J, Colasurdo G, Rutigliano J A, Chiappetta C L, Goleniewska K, O'Neal J F, Graham B S, Peebles R S. IL-13 is associated with reduced illness and replication in primary respiratory syncytial virus infection in the mouse. Microbes Infect 2006; 8: 2880–2889
   PubMed Web of Science ®Google Scholar
• Ermers M J, Hoebee B, Hodemaekers H M, Kimman T G, Kimpen J L, Bont L. IL-13 genetic polymorphism identifies children with late wheezing after respiratory syncytial virus infection. J Allergy Clin Immunol 2007; 119: 1086–1091
   PubMed Web of Science ®Google Scholar
• Boutten A, Bonay M, Laribe S, Leseche G, Castier Y, Leçon-Malas V, Fournier M, Durand G, Aubier M, Dehoux M, Crestani B. Decreased expression of interleukin 13 in human lung emphysema. Thorax 2004; 59: 850–854
   PubMed Web of Science ®Google Scholar
• Mufson M A, Örvell C, Rafnar B, Norrby E. Two distinct subtypes of human respiratory syncytial virus. J Gen Virol 1985; 66: 2111–2124
   PubMed Web of Science ®Google Scholar
• Lukacs N W, Moore M L, Rudd B D, Berlin A A, Collins R D, Olson S J, Ho S B, Peebles R S. Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus. Am J Pathol 2006; 169: 977–986
   PubMed Web of Science ®Google Scholar
• Fodha I, Vabret A, Ghedira L, Seboui H, Chouchane S, Dewar J, Gueddiche N, Trabelsi A, Boujaafar N, Freymuth F. Respiratory syncytial virus infections in hospitalized infants: association between viral load, virus subgroup, and disease severity. J Med Virol 2007; 79: 1951–1958
   PubMed Web of Science ®Google Scholar
• Plotkowski M C, Puchelle E, Beck G, Jacquot J, Hannoun C. Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus. Am Rev Respir Dis 1986; 134: 1040–1044
   PubMed Web of Science ®Google Scholar
• Avadhanula V, Rodriguez C A, Devincenzo J P, Wang Y, Webby R J, Ulett G C, Adderson E E. Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. J Virol 2006; 80: 1629–1636
   PubMed Web of Science ®Google Scholar
• Avadhanula V, Wang Y, Portner A, Adderson E. Nontypeable Haemophilus influenzae and Streptococcus pneumoniae bind respiratory syncytial virus glycoprotein. J Med Microbiol 2007; 56: 1133–1137
   PubMed Web of Science ®Google Scholar
• Corbeil L B, Arnold K F, Kimball R, Berghaus L, Gershwin L J. Specificity of IgG and IgE antibody responses to Haemophilus somnus infection of calves. Vet Immunol Immunopathol 2006; 113: 191–199
   PubMed Web of Science ®Google Scholar
• Monso E, Ruiz J, Rosell A, Manterola J, Fiz J, Morera J, Ausina V. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995; 152: 1316–1320
   PubMed Web of Science ®Google Scholar
• Cabello H, Torres A, Celis R, El-Ebiary M, Puig de la Bellacasa J, Xaubet A, Gonzalez J, Agusti C, Soler N. Bacterial colonization of distal airways in healthy subjects and chronic lung disease: A bronchoscopic study. Eur Respir J 1997; 10: 1137–1144
   PubMed Web of Science ®Google Scholar
• Zalacain R, Sobradillo V, Amilibia J, Barron J, Achotegui V, Pijoan J I, Llorente J L. Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur Respir J 1999; 13: 343–348
   PubMed Web of Science ®Google Scholar
• Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 1999; 14: 1015–1022
   PubMed Web of Science ®Google Scholar
• Hill A T, Campbell E J, Hill S L, Bayley D L, Stockley R A. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 2000; 109: 288–295
   PubMed Web of Science ®Google Scholar
• Chin C L, Manzel L J, Lehman E E, Humlicek A L, Shi L, Starner T D, Denning G M, Murphy T F, Sethi S, Look D C. Haemophilus influenzae from patients with chronic obstructive pulmonary disease exacerbation induce more inflammation than colonizers. Am J Respir Crit Care Med 2005; 172: 85–91
   PubMed Web of Science ®Google Scholar
• Sajjan U S, Jia Y, Newcomb D C, Bentley J K, Lukacs N W, LiPuma J J, Hershenson M B. H. influenzae potentiates airway epithelial cell responses to rhinovirus by increasing ICAM-1 and TLR3 expression. FASEB J 2006; 20: 2121–2123
   PubMed Web of Science ®Google Scholar
• Wilkinson T M, Hurst J R, Perera W R, Wilks M, Donaldson G C, Wedzicha J A. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD. Chest 2006; 129: 317–324
   PubMed Web of Science ®Google Scholar
• Sethi S. Coinfection in exacerbations of COPD: a new frontier. Chest 2006; 129: 223–224
   PubMed Web of Science ®Google Scholar
• Donaldson G C, Seemungal T A, Patel I S, Lloyd-Owen S J, Wilkinson T M, Wedzicha J A. Longitudinal changes in the nature, severity and frequency of COPD exacerbations. Eur Respir J 2003; 22: 931–936
   PubMed Web of Science ®Google Scholar